ClinicalTrials.Veeva

Menu

In-office Bleaching Using a Violet Light

U

University of Sao Paulo

Status

Completed

Conditions

Dentin Sensitivity
Tooth Bleaching

Treatments

Procedure: Hybrid technique 2
Procedure: Hybrid technique 1
Procedure: Violet LED bleaching 1
Procedure: Photochemical protocol 2
Procedure: 35% Hydrogen peroxide bleaching
Procedure: Photochemical protocol 1
Procedure: Violet LED bleaching 2
Procedure: 30% Carbamide peroxide bleaching

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this clinical study is to evaluate the effect of the whitening treatment performed with the violet LED light (405-410 nm), with or without a bleaching gel, on the tooth color changes (immediate and long-term), tooth sensitivity, satisfaction of participants in relation to the technique and impact on their quality of life. After being informed of the objectives of the study, 200 participants will be selected and randomly divided into a treatment group (n = 25): G1 - 35% hydrogen peroxide (HP) (4 sessions, 1 session/week); G2 - 30% carbamide peroxide (CP) (4 sessions, 1 session/week); G3 - Violet LED (405-410 nm, 4 sessions, 1 session/week); G4 - Violet LED (405-410 nm, 4 sessions, 2 sessions/week); G5 - Violet LED associated to 35% hydrogen peroxide (4 sessions, 1 session / week); G6 - Violet LED associated to 30% carbamide peroxide (4 sessions, 1 session / week); G7 - hybrid technique HP (Violet LED + application of 35% hydrogen peroxide + violet LED) (4 sessions, 1 session/week); G8 - Hybrid technique CP HP (Violet LED + application of 30% carbamide peroxide + violet LED) (4 sessions, 1 session/week). The color evaluation will be performed at predetermined times (before and immediately after treatment, 14 days after completion of bleaching and 3, 6 and 12 months after completion of bleaching), and quantitatively evaluated by colorimetric tests (objective and subjective) and spectrophotometry. In addition, it will be evaluated the tooth sensitivity during and after (48 hours) tooth whitening (VAS Scale), satisfaction with the treatment and impact on quality of life (OHIP-14 questionnaire). The data, except for survey data of satisfaction (descriptive evaluation), will be subjected to statistical analysis to determine the homogeneity and normality of the sample and for comparison between treatment groups, considering a 5% significance level.

Full description

The objective of this clinical study is to evaluate the effect of the whitening treatment performed with the violet LED light (405-410 nm), with or without a bleaching gel, on the tooth color changes (immediate and long-term), tooth sensitivity, satisfaction of participants in relation to the technique and impact on their quality of life.

This study was approved by the research ethics committee of School of Dentistry of University of Sao Paulo (Protocol# 1.981.756). The experimental design is in according to CONSORT. The present research will be a blind, parallel and randomized study with similar allocation between the treatment groups. It will be included 200 participants, selected among the patients of the Special Laboratory of lasers in dentistry (LELO-FOUSP). After being being informed of the objectives of the study the participants will be randomly divided into a treatment group (n = 25):

G1 - In-office bleaching performed with 35% hydrogen peroxide (4 sessions, 1 session/week).

G2 - In-office bleaching performed with 30% carbamide peroxide (4 sessions, 1 session/week).

G3 - In-office bleaching performed with Violet LED (405-410 nm, 4 sessions, 1 session/week).

G4 - In-office bleaching performed with Violet LED (405-410 nm, 4 sessions, 2 sessions/week).

G5 - In-office bleaching performed Violet LED associated to 35% hydrogen peroxide (4 sessions, 1 session / week).

G6 - In-office bleaching performed Violet LED associated to 30% carbamide peroxide (4 sessions, 1 session / week).

G7 - hybrid technique HP (Violet LED + application of 35% hydrogen peroxide + violet LED) (4 sessions, 1 session/week).

G8 - Hybrid technique CP HP (Violet LED + application of 30% carbamide peroxide + violet LED) (4 sessions, 1 session/week).

The primary outcome of this study is the color alteration, which will be evaluated quantitatively by colorimetric (subjective) and spectrophotometric (objective) tests. Additionally, will be evaluated dental sensitivity during and after treatment (predetermined times), patient satisfaction regarding the treatment, and impact on patient quality of life (questionnaire OHIP-14).

The color measurement will be blind, in predetermined times (before the treatment, immediately after the treatment, 14 days after, 3 months after, 6 months after and 12 months after). It will be performed by two methods: subjectively, with a color scale; and objectively, with a clinical spectrophotometer.

The evaluation of dental sensitivity will be measured with a Visual analogue scale (VAS). It will be performed immediately after the treatment and 48 hours after the treatment.

The patient satisfaction regarding the treatment will be measured with a questionnaire for self-evaluation of the treatment, and will be applied 14 days after the end of treatment, 3 months after, 6 months after and 12 months after.

The evaluation of quality of life of the patients will be performed with the OHIP-14 questionnaire, which will be applied after the end of the treatment.

Enrollment

200 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Presence of all the teeth, without restorations or caries on anterior teeth.
  • Patients presenting the canine tooth color A3 (according to Vita classical scale) or darker.

Exclusion criteria

  • Patients presenting systemic pathologies
  • Patients presenting periodontal diseases
  • Smokers or patients with systematic use of alcohol
  • Patients presenting teeth with color alterations by tetracycline, fluorosis, endodontic treatments.
  • Patients with historic of self-referenced sensitivity
  • Pregnant or Breastfeeding period patients
  • Presence of restorations on anterior teeth
  • Patients presenting bruxism or systematic use of analgesics or anti-inflammatory drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 8 patient groups

G1 - 35% Hydrogen peroxide bleaching
Active Comparator group
Description:
In-office bleaching performed with 35% hydrogen peroxide (4 sessions, 1 session/week);
Treatment:
Procedure: 35% Hydrogen peroxide bleaching
G2 - 30% Carbamide peroxide bleaching
Active Comparator group
Description:
In-office bleaching performed with 30% carbamide peroxide (4 sessions, 1 session/week);
Treatment:
Procedure: 30% Carbamide peroxide bleaching
G3 - Violet LED bleaching 1
Experimental group
Description:
In-office bleaching performed with Violet LED (405-410 nm, 4 sessions, 1 session/week);
Treatment:
Procedure: Violet LED bleaching 1
G4 - Violet LED bleaching 2
Experimental group
Description:
In-office bleaching performed with Violet LED (405-410 nm, 4 sessions, 2 sessions/week);
Treatment:
Procedure: Violet LED bleaching 2
G5 - Photochemical protocol 1
Experimental group
Description:
In-office bleaching performed Violet LED associated to 35% hydrogen peroxide (4 sessions, 1 session / week);
Treatment:
Procedure: Photochemical protocol 1
G6 - Photochemical protocol 2
Experimental group
Description:
In-office bleaching performed Violet LED associated to 30% carbamide peroxide (4 sessions, 1 session / week)
Treatment:
Procedure: Photochemical protocol 2
G7 - Hybrid technique 1
Experimental group
Description:
hybrid technique HP (Violet LED + application of 35% hydrogen peroxide + violet LED) (4 sessions, 1 session/week)
Treatment:
Procedure: Hybrid technique 1
G8 - Hybrid technique 2
Experimental group
Description:
Hybrid technique CP HP (Violet LED + application of 30% carbamide peroxide + violet LED) (4 sessions, 1 session/week).
Treatment:
Procedure: Hybrid technique 2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems